Intercept Pharmaceuticals, Inc.

WELLS FARGO & COMPANY/MN

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

72,409

Value ($000)

1,342

Weight

0.0%

2014 Q1 - 2023 Q3 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	1,342	0.0%	72,409	9/30/2023
2023 Q2	8/15/2023	1,609	0.0%	145,454	6/30/2023
2023 Q1	5/12/2023	1,576	0.0%	117,338	3/31/2023
2022 Q4	2/13/2023	853	0.0%	68,993	12/31/2022
2022 Q3	11/14/2022	1,297	0.0%	92,992	9/30/2022
2022 Q2	8/12/2022	991	0.0%	71,821	6/30/2022
2022 Q1	5/16/2022	1,450	0.0%	89,188	3/31/2022
2021 Q4	2/14/2022	1,494	0.0%	91,780	12/31/2021
2021 Q3	11/15/2021	2,334	0.0%	157,212	9/30/2021
2021 Q2	8/16/2021	1,446	0.0%	72,380	6/30/2021
2021 Q1	5/13/2021	895	0.0%	38,743	3/31/2021
2020 Q4	2/9/2021	1,787	0.0%	72,320	12/31/2020
2020 Q3	11/5/2020	1,953	0.0%	47,074	9/30/2020
2020 Q2	8/13/2020	3,709	0.0%	77,408	6/30/2020
2020 Q1	5/14/2020	5,054	0.0%	80,258	3/31/2020
2019 Q4	2/14/2020	14,187	0.0%	114,488	12/31/2019
2014 Q1	5/15/2014	6,216	0.0%	18,849	3/31/2014